IQ EQ Fund Management’s AbbVie ABBV Stock Holding History

IQ EQ Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Hold	3,743	–	–	0.06%	226
2025 Q4	$855K	Hold	3,743	–	–	0.06%	225
2025 Q3	$867K	Sell	3,743 -135	-3%	-$27.5K	0.06%	226
2025 Q2	$720K	Hold	3,878	–	–	0.06%	243
2025 Q1	$813K	Sell	3,878 -1,236	-24%	-$240K	0.1%	198
2024 Q4	$909K	Sell	5,114 -62	-1%	-$11.4K	0.11%	188
2024 Q3	$1.02M	Sell	5,176 -160	-3%	-$29.9K	0.11%	220
2024 Q2	$915K	Sell	5,336 -103	-2%	-$17.1K	0.1%	214
2024 Q1	$990K	Buy	5,439 +1,232	+29%	+$212K	0.11%	201
2023 Q4	$652K	Sell	4,207 -6,225	-60%	-$908K	0.08%	225
2023 Q3	$1.55M	Sell	10,432 -1,816	-15%	-$267K	0.32%	98
2023 Q2	$1.65M	Hold	12,248	–	–	0.31%	102
2023 Q1	$1.95M	Sell	12,248 -1,271	-9%	-$194K	0.37%	90
2022 Q4	$2.18M	Buy	13,519 +380	+3%	+$58.3K	0.45%	84
2022 Q3	$1.76M	Sell	13,139 -1,554	-11%	-$223K	0.4%	92
2022 Q2	$2.25M	Buy	14,693 +312	+2%	+$47.7K	0.45%	79
2022 Q1	$2.33M	Sell	14,381 -4,239	-23%	-$616K	0.38%	95
2021 Q4	$2.52M	Sell	18,620 -3,646	-16%	-$431K	0.39%	88
2021 Q3	$2.4M	Sell	22,266 -5,701	-20%	-$651K	0.37%	92
2021 Q2	$3.15M	Buy	27,967 +4,122	+17%	+$464K	0.48%	73
2021 Q1	$2.58M	Buy	23,845 +11,182	+88%	+$1.2M	0.45%	74
2020 Q4	$1.36M	Buy	12,663 +454	+4%	+$43.6K	0.31%	100
2020 Q3	$1.07M	Buy	12,209 +394	+3%	+$37.1K	0.32%	77
2020 Q2	$1.16M	Sell	11,815 -206	-2%	-$18.1K	0.39%	71
2020 Q1	$916K	Buy	12,021 +243	+2%	+$20.7K	0.38%	71
2019 Q4	$1.04M	Sell	11,778 -1,103	-9%	-$91.6K	0.33%	79
2019 Q3	$975K	Hold	12,881	–	–	0.32%	84
2019 Q2	$936K	Buy	+12,881	New	+$1.01M	0.3%	87
2018 Q4	$949K	Hold	10,296	–	–	0.35%	84
2018 Q3	$1M	Buy	10,296 +350	+4%	+$33.2K	0.27%	87
2018 Q2	$921K	Buy	+9,946	New	+$971K	0.25%	86
2017 Q1	$791K	Hold	10,907	–	–	0.15%	95
2016 Q4	$771K	Sell	10,907 -309	-3%	-$18.9K	0.14%	93
2016 Q3	$751K	Sell	11,216 -75	-0.7%	-$4.86K	0.14%	89
2016 Q2	$747K	Sell	11,291 -21,930	-66%	-$1.34M	0.14%	84
2016 Q1	$2.04M	Sell	33,221 -113	-0.3%	-$6.3K	0.37%	58
2015 Q4	$2.21M	Sell	33,334 -2,078	-6%	-$120K	0.38%	55
2015 Q3	$2.1M	Sell	35,412 -1,876	-5%	-$122K	0.34%	55
2015 Q2	$2.74M	Sell	37,288 -8,905	-19%	-$581K	0.39%	52
2015 Q1	$3.06M	Sell	46,193 -5,056	-10%	-$305K	0.41%	51
2014 Q4	$3.39M	Buy	+51,249	New	+$3.23M	0.49%	48

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IQ EQ Fund Management's ABBV Position: Q1 2026 in Review

IQ EQ Fund Management held its AbbVie (ABBV) position steady in Q1 2026 at 3,743 shares worth $814K. The position accounts for 0.06% of the portfolio, ranked #226.

IQ EQ Fund Management first reported a position in ABBV in Q4 2014 and has held it in 41 quarters since. The position peaked at $3.39M in Q4 2014. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

IQ EQ Fund Management held 3,743 shares of AbbVie worth $814K as of Q1 2026.
IQ EQ Fund Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.06% of IQ EQ Fund Management's portfolio in Q1 2026, its #226 holding.
IQ EQ Fund Management first reported a position in AbbVie in Q4 2014 and has held it in 41 quarters since.
IQ EQ Fund Management's AbbVie position peaked at $3.39M in Q4 2014.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.